Zevra Therapeutics Down Over 24%, on Pace for Largest Percent Decrease Since March 2021 -- Data Talk

Zevra Therapeutics, Inc. (ZVRA) is currently at $9.45, down $3.07 or 24.52%

--Would be lowest close since April 2, 2026, when it closed at $9.40

--On pace for largest percent decrease since March 4, 2021, when it fell 28.51%

--Currently down three of the past five days

--Down 26.00% this week; worst weekly performance since the week ending Jan. 8, 2021, when it fell 50.00%

--Down 34.1% month-to-date; on pace for worst month since Jan. 2021, when it fell 46.16%

--Up 5.47% year-to-date

--Down 97.5% from its all-time closing high of $378.08 on Sept. 18, 2015

--Down 15.85% from 52 weeks ago (July 25, 2025), when it closed at $11.23

--Down 35.93% from its 52-week closing high of $14.75 on July 8, 2026

--Up 30.71% from its 52-week closing low of $7.23 on Sept. 15, 2025

--Traded as low as $9.10; lowest intraday level since March 31, 2026, when it hit $8.81

--Down 27.32% at today's intraday low; largest intraday percent decrease since March 4, 2021, when it fell as much as 32.81%

All data as of 1:29:38 PM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

July 24, 2026 13:32 ET (17:32 GMT)